1. Dabrafenib and its use in the treatment of metastatic melanoma. (August 2015) Authors: Bowyer, Samantha; Lee, Rebecca; Fusi, Alberto; Lorigan, Paul Journal: Melanoma management Issue: Volume 2:Number 3(2015) Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Life-threatening polymyositis with spontaneous hematoma induced by nivolumab in a patient with previously resected melanoma. Issue 1 (February 2021) Authors: Liu, Wing K.; Naban, Nabeel; Kaul, Arvind; Patel, Nirav; Fusi, Alberto Journal: Melanoma research Issue: Volume 31:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium. Issue 7 (July 2019) Authors: Andrews, Miles C; Berry, Donald A; Block, Matthew S; Boland, Genevieve M; Bollin, Kathryn B; Carlino, Matteo S; Carvajal, Richard D; Cohen, Jonathan; Davar, Diwakar; Delman, Keith A; Dummer, Reinhard; Farwell, Michael D; Fisher, David E; Fusi, Alberto; Glitza, Isabella C; de Gruijl, Tanja D; Gyor... Journal: Lancet oncology Issue: Volume 20:Issue 7(2019) Page Start: e378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancer. Issue 2 (May 2015) Authors: Howell, Matthew; Lee, Rebecca; Bowyer, Samantha; Fusi, Alberto; Lorigan, Paul Journal: Lung cancer Issue: Volume 88:Issue 2(2015:May) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PD-L1 expression as a potential predictive biomarker. Issue 13 (October 2015) Authors: Fusi, Alberto; Festino, Lucia; Botti, Gerado; Masucci, Giuseppe; Melero, Ignacio; Lorigan, Paul; Ascierto, Paolo A Journal: Lancet oncology Issue: Volume 16:Issue 13(2015) Page Start: 1285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PI3K/PTEN/AKT/mTOR polymorphisms: Association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab‐docetaxel. Issue 4 (7th February 2015) Authors: Pfisterer, Katharina; Fusi, Alberto; Klinghammer, Konrad; Knödler, Maren; Nonnenmacher, Anika; Keilholz, Ulrich Journal: Head & neck Issue: Volume 37:Issue 4(2015:Apr.) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The importance for immunoregulation for long-term cancer control. (August 2017) Authors: Fusi, Alberto; Dalgleish, Angus Journal: Future oncology Issue: Volume 13:Number 18(2017) Page Start: 1619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The role of chemotherapy in the modern management of melanoma. (November 2014) Authors: Lee, Rebecca Jane; Ul-Ain-Tariq, Noor; Fusi, Alberto; Bowyer, Samantha; Lorigan, Paul Journal: Melanoma management Issue: Volume 1:Number 2(2014) Page Start: 173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The successful treatment of metastatic androgen receptor–positive tumours of parotid origin with androgen receptor blockade and immunotherapy. (May 2019) Authors: Dalgleish, Angus G.; Di Palma, Silvana; Nathan, Kannon; Powell, Barry; Patel, Nirav; Fusi, Alberto Journal: European journal of cancer Issue: Volume 113(2019) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗